Gloshell
Ingredients

Ingredient Dictionary

DISODIUM OLEYL SULFOSUCCINATE

Molecular structure

Definition

US FDA substance register · UNII 6X9K0QRH71 · registered name DISODIUM 1-(OLEOYL)-2-SULPHONATOSUCCINATE · single chemical substance

Source: US FDA Unique Ingredient Identifier (UNII)

Cosmetic roles

Washes away surface impuritiesCLEANSINGSurfactant that lifts dirtSURFACTANT - CLEANSINGBoosts latherSURFACTANT - FOAM BOOSTINGHelps poorly soluble ingredients dissolve in waterSURFACTANT - HYDROTROPE

Safety & regulatory references

Not classified under Korea’s toxic-substance GHS list · existing chemical substance

Source: Korea toxic substances GHS register (NIER)

Other restriction: ban substances that deplete the ozone layer

Source: EU CosIng ingredient list

More data — names, identifiers, properties, test records, literature

Names & identifiers

DISODIUM OLEYL SULFOSUCCINATEINCI다이소듐올레일설포석시네이트Korean label name (MFDS standard)
CAS No.chemical registry number
131456-48-9
CAS No.chemical registry number
94021-02-0
CAS No.chemical registry number
94213-67-9
EC No.EU chemical inventory number
303-773-5
DTXSIDUS EPA chemical ID
DTXSID401020320
DTXCIDUS EPA compound ID
DTXCID301841450
IUPAC
Disodium 4-{[(9Z)-octadec-9-en-1-yl]oxy}-4-oxo-3-sulfonatobutanoate
Molecular formula
C22H38Na2O7S
Molecular weight
492.58 g/mol

What products actually use it for

What the 4 products reported to the US EPA with this ingredient use it for. Products outside cosmetics are included, so the top few rows are its main uses.

  • Cleaning agent1
  • Foamant1
  • Solubility enhancer1
  • Surfactant (surface active agent)1

Source: US EPA CompTox dashboard

Irritation and sensitisation studies

1 skin studies and 2 eye studies are on record.

Classed as low1

The study conclusions largely agree (100%). These tests are on the raw material itself; irritation at the amount in a finished product is a different question.

See all 3 studies
  • Not likely to be sensitizing
    skin sensitisation: in vivo (LLNA) · Screening · according to OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay) July 2010 according to EU Method B.42 (Skin Sensitisation: Local Lymph Node Assay) May 2008, including most recent amendments according to EPA OPPTS 870.2600 (Skin Sensitisation) March 2003
  • Ambiguous
    eye irritation: in vivo · Screening · OECD Guideline 405 (Acute Eye Irritation / Corrosion) equivalent or similar to
  • Corrosive or Irritation Persists for > 21 days
    eye irritation: in vivo · Screening · other guideline: FHSA procedure according to

Source: US EPA CompTox dashboard

Linked databases 11